ASB16 and adrenal cortex carcinoma: To explore whether dysregulation of ASB16-AS1 participate in the proliferation of adrenocortical carcinoma cells, siRNAs specifically targeting endogenous ASB16-AS1 were transfected into SW-13 and H295R cells, respectively (Fig. 2a).